InvestorsHub Logo
Followers 657
Posts 24622
Boards Moderated 2
Alias Born 07/16/2006

Re: None

Friday, 04/15/2016 9:14:31 AM

Friday, April 15, 2016 9:14:31 AM

Post# of 1616
Correspondence from the CEO ......

From: tom.barr@bioamd.com
To: chikhat@hotmail.com
Subject: RE: Sysmex .....
Date: Thu, 14 Apr 2016 16:25:37 +0100

Hi John

Apologies, I have searched and it appears that I missed your mail of 11 September 2015 as it ended up in my Junk for some reason. I have white listed you.

We don’t know why Sysmex canned the project so suddenly – it’s all very shocking here as well. They can’t steal it, as it’s our IP and they lose the licence with the termination - and they will ideally require our staff to get it finalised.

The plan now is to get the project documented in summary (will be drafted by tomorrow) and to get out there and try to find another partner. We have contacted one prospect already who contacted us during the project (we could not speak to them then) and who have now have requested data. Another big medical company also wanted to know if COAG became available, so we will go back to them, too. Plus there will be another 4 or 5 targets we hope to work up. Obviously time is of the essence.

Sysmex: I am livid. It was such a turn-around that something must have gone on internally; there is nothing wrong with our technology, the Study results were superb.

I don’t play golf.

Regards

Tom


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.